The Royal Pharmaceutical Society (RPS) and the Pharmacists' Defence Association (PDA) have responded to the Department of Health and Social Care (DHSC)
consultation on pharmacy supervision, which was launched in early December last year.
The DSHC set out proposals to amend the Medicines Act 1968 and The Human Medicines Regulations 2012 to allow registered pharmacy technicians to work without
direct supervision, which in turn will help free up pharmacists to provide more clinical care and reduce GP appointments.
While the RPS supported the legislative change, it highlighted a range of topics that should be considered and clarified in regulations and guidance.
According to RPS, the new concept of 'authorisation', including around documentation, accountability, and the role of superintendent pharmacist and responsible
pharmacist, needs clarification.
In partnership with the Prescription Charges Coalition (PCC), the Royal Pharmaceutical Society (RPS) has taken a significant step by urging political
leaders to abolish prescription charges for individuals with long-term conditions.
Tase Oputu, Chair of the RPS England Pharmacy Board, signed an open letter on Thursday, calling on party leaders to address this pressing issue.
The letter emphasises the outdated nature of the current exemption list, which forces individuals with chronic conditions like Parkinson's, cystic fibrosis,
and HIV to bear the cost of their essential medications.
It urges party leaders to urgently review and update the exemption list to ensure equitable access to necessary medicines.
"Nobody should face a financial barrier to accessing the medicines they need," Oputu stated.
A new survey by the Royal College of Nursing (RCN) has made a concerning revelation about the rise in nursing students contemplating quitting.
Nearly half of nursing students in England are contemplating quitting their courses before completion.
This alarming trend threatens the NHS England Long Term Workforce Plan, published a year ago, which aims to significantly expand the nursing workforce by 2036/37.
The survey also highlights a dramatic 20 per cent decrease in the number of students enrolling in nursing degree apprenticeships over the past two academic years.
This decline underscores the urgency of addressing the challenges faced by nursing students, including increasing financial pressures due to the cost of living,
insufficient teaching and supervision, and mental health issues as the primary reasons for consifdering quitting.
The General Pharmaceutical Council (GPHC), Royal Pharmaceutical Society (RPS), Company Chemists Association (CCA), Association of Pharmacy
Technicians UK (APTUK), National Pharmacy Association (NPA), Guild of Healthcare Pharmacists, Pharmacists' Defence Association (PDA), and Independent
Pharmacies Association (IPA) have released a joint statement in response to the far-right riots across the UK.
They emphasised their united stance, declaring zero tolerance for racism towards colleagues or the public in any form.
The joint statement reads: "We are shocked and saddened by the violent public disorder events in recent days.
"We acknowledge how all sectors of the pharmacy profession may be impacted and recognise the challenges that this level of overt aggression can have on
people's ability or willingness to live their daily lives.
"The pharmacy workforce deserves peace and safety, not fear and harm. We stand united in having a zero tolerance of racism towards our colleagues or the
public in whatever form it takes."
Meanwhile, Community Pharmacy England (CPE) has expressed concerns that protests and violent disorder in various towns and cities across England may impact
the ability of community pharmacies to operate.
The Royal Pharmaceutical Society (RPS) has announced the results of the elections to vacant positions on the RPS Scottish and English Country Boards that took
place at the meeting on June 18.
The Scottish Pharmacy Board elected Jonathan Burton, FRPharmS, as their new Chair and Audrey Thompson to the RPS Assembly, the organisation's governing body.
Jonathan is a community pharmacist and an independent prescriber affiliated with the Right Medicine Pharmacy group in Stirling. He has played an integral role in
the inception, development and delivery of Pharmacy First services in Scotland.
He is an RPS Fellow and received an MBE in 2018 for services to healthcare. Jonathan is also the recipient of the 2023 RPS Charter Award. He previously served as
Chair of the Scottish Pharmacy Board from 2019 to 2021.
"Serving as Chair is a great privilege," said Jonathan while expressing his delight at being elected as the Chair of the Scottish Pharmacy Board.
In a surprising move that has divided the pharmacy profession, the General Pharmaceutical Council (GPhC) has sanctioned hundreds of pharmacies to allow
patients to self-select certain Pharmacy (P) medicines, a decision met with strong opposition from the Royal Pharmaceutical Society (RPS) as well as from the
Pharmacy Defense Association (PDA).
In a statement, RPS shared that at a board meeting held on 19th June, they expressed "disappointment" over what they described as a lack of prior consultation
and comprehensive communication from the GPhC regarding the implications of this policy shift.
They argue that allowing patients to self-select certain P medicines could potentially jeopardize established professional guidelines and compromise the role of
pharmacists in ensuring safe medication use.
"Enabled by the General Pharmaceutical Council, we understand that hundreds of pharmacies, from large multiples to small independents, have been approved by the
regulator to enable patients to self-select certain P medicines," the statement said.
In a unified effort to improve women's healthcare, four leading organisations-the Company Chemists' Association (CCA), the National Pharmacy Association (NPA),
the Royal Pharmaceutical Society (RPS), and the Faculty of Sexual and Reproductive Healthcare (FSRH)-are calling for the commissioning of a National Emergency
Hormonal Contraception (EHC) service in England.
They are proposing that this service be provided free of charge through community pharmacies to women of all ages across the country.
They emphasised that such a service would "not only transform access to care for all women, but directly tackle health inequalities and vastly improve health
outcomes."
A judicial review claim launched by the British Medical Association (BMA) against the General Medical Council (GMC) has parallelly intensified Pharmacists'
Defence Association's (PDA) scrutiny over the use of the term 'pharmacy professionals'.
PDA has criticised the evolving definition of 'pharmacy professionals,' and the potential risks to patient safety amidst regulatory ambiguity as part of "a far
wider agenda."
Concerns stem from what the PDA perceives as a blurring of distinctions between pharmacists and pharmacy technicians as "attempted homogenisation" by bodies like
the General Pharmaceutical Council (GPhC), NHS, and Royal Pharmaceutical Society (RPS).
Raising similar issue as the BMA against the GMC over its use of 'medical professionals for doctors and Medical Associate Professions (MAPs), Mark Koizol,
Chairman of the PDA has said:
Expressing apprehension over the concerning decline in the nursing workforce, Sir Julian Hartley, CEO of NHS Providers, urged the forthcoming government
to bolster investment in nursing education and enhance support for student nurses.
Recent analysis from the Royal College of Nursing (RCN) has projected that the NHS Long Term Workforce Plan will fall short by 10,000 new nurses by 2025.
Commenting on the RCN analysis, Sir Hartley underscored the critical importance of having an adequate number of nurses to ensure the delivery of safe,
high-quality patient care.
"Without enough nurses, the delivery of safe, high-quality patient care is compromised," he said.
He cautioned that the predicted shortfall in nurses would exacerbate existing pressures on the NHS, resulting in long waiting times, delayed treatments and
staff burnout.
Cervical screening is one of the best ways to protect women from cervical cancer, which claims nearly two lives daily in England, according to NHS England.
Therefore, all women and those with a cervix between the ages of 25 and 64 are encouraged to attend cervical screening when invited.
Sadly, 3 in 10 of those eligible for cervical screening do not take up the potentially life-saving offer, as revealed by the NHS Cervical Screening Programme,
England 2022-2023 annual report.
Pharmacist Thorrun Govind, also a Healthcare Lawyer (Brabners LLP), underscores the significant role pharmacists and pharmacy teams can play in promoting cervical
cancer screening.
The former Chair of the Royal Pharmaceutical Society (RPS) in England told Pharmacy Business: "Pharmacists and pharmacy teams are a trusted part of the local
community. They therefore have a key part in promoting cervical cancer screening."
Thorrun Govind, a former chair of the English Pharmacy Board of the Royal Pharmaceutical Society, has joined Brabners' regulatory & professional conduct team.
With nearly a decade of experience as a GPhC-registered pharmacist, Govind will provide guidance on regulatory and professional conduct issues.
Govind's expertise extends to healthcare advisory and disputes involving NHS Trusts and social care organisations.
She has been recognised as the 'Young Pharmacist of the Year' by Pharmacy Business Magazine and is a frequent commentator on public health and healthcare law
for major television networks.
Her appointment underscores Brabners' commitment to offering top-tier legal services to the healthcare industry.
Following the publication of a new study by the British Medical Journal (BMJ) that estimates the economic impact and prevelance of hazardous NSAID
prescribing in England, the Royal Pharmaceutical Society (RPS) has underscored the pressing need for enhanced safety measures in medication management.
The study, led by RPS Fellow Rachel Elliott, reveals significant health and financial costs associated with the high-risk prescribing of oral non-steroidal
anti-inflammatory drugs (NSAIDs) among vulnerable populations.
James Davies, Director for England at the RPS, emphasised the critical findings of the research.
"Improving the safety of NSAID prescribing requires a multi-pronged approach, that educates and supports prescribers on the risk, as well as uses the skills
of pharmacists in the primary care team to help identify higher risk patients and prescribing scenarios," Davies remarked.
The study highlights that NSAIDs, while effective in managing pain and inflammation, are associated with serious adverse events, including gastrointestinal
bleeding, renal dysfunction, and cardiovascular issues.
Pharmacy2U has joined thousands of pharmacists in launching the new NHS Pharmacy First service in England.
The new service, which was first launched on 31 January 2024, enables pharmacists to treat seven common health conditions without the need for a GP appointment
or prescription.
Over 95 per cent of all community pharmacies in the country (10,265 in total) have signed up to provide the service, which is aimed at easing pressure on GP
services while giving patients quick and accessible care.
Under the Pharmacy First service, the online pharmacy is offering same-day appointments to manage six conditions: sinusitis, an infected insect bite, sore
throat, UTIs, shingles and impetigo.
Pharmacy2U's CEO Kevin Heath said that they support the initiative fully and that the service will play a major role in providing patients easy and direct
access to pharmacists.
Within 24 hours of the Princess of Wales, Kate Middleton's, cancer diagnosis, National Health Service (NHS) England saw a 373% spike in visits to its
cancer page, highlighting the growing focus on cancer awareness.
Similarly, charities like Macmillan Cancer Support charity experienced increased traffic, with nearly 100,000 visits to their support pages since the announcement.
Traffic to the NHS website's cancer symptoms page surged significantly, recording a remarkable 4,172 visits within three hours of the release of the Princess's
video message.
This sudden increase translated to an average of one visit every three seconds, a substantial rise from the 1,922 visits recorded during the same timeframe a week
earlier.
Notably, visits to the symptoms page peaked immediately after the announcement, with 1,678 visits recorded between 6 pm and 7 pm on the day of the announcement.